J&J 10-Q: Debt Maturities and Financial Snapshot
Ticker: JNJ · Form: 10-Q · Filed: Apr 23, 2025 · CIK: 200406
Sentiment: neutral
Topics: 10-Q, debt, financials
TL;DR
JNJ 10-Q out: Lots of debt notes maturing between 2028-2055. Financials look stable.
AI Summary
Johnson & Johnson filed its 10-Q for the period ending March 30, 2025. The filing details the company's financial position, including various debt instruments such as notes due in 2028, 2029, 2032, 2033, 2035, 2036, 2037, 2044, 2045, and 2055. It also references retained earnings and accumulated other comprehensive income as of December 29, 2024.
Why It Matters
This filing provides insight into Johnson & Johnson's debt structure and financial health, which can influence investor confidence and the company's ability to fund future operations and growth.
Risk Assessment
Risk Level: low — The filing is a routine quarterly report and does not indicate any immediate or significant new risks.
Key Numbers
- 2025-03-30 — Reporting Period End Date (Quarterly financial data is reported as of this date.)
- 2024-12-29 — Previous Year End Date (Comparative financial data from the prior fiscal year end.)
Key Players & Entities
- JOHNSON & JOHNSON (company) — Filer
- 20250330 (date) — Period of Report
- 20250423 (date) — Filing Date
- 2024-12-29 (date) — Previous Fiscal Year End
- 2028 (date) — Debt Maturity Year
- 2055 (date) — Debt Maturity Year
FAQ
What is the total value of the debt instruments listed in the filing?
The filing lists various debt notes with specific maturity dates (e.g., November 2028, February 2029, June 2032, etc.) but does not provide a consolidated total dollar amount for all outstanding debt in this excerpt.
What is the fiscal year end for Johnson & Johnson?
Johnson & Johnson's fiscal year ends on December 28.
What is the primary industry classification for Johnson & Johnson?
Johnson & Johnson is classified under 'Pharmaceutical Preparations' with the SIC code 2834.
What are some of the specific debt instruments mentioned?
The filing mentions notes due November 2028 (A1.150%), February 2029 (A2.700%), June 2032 (A3.20%), February 2033 (A3.050%), 2035 (A1.650%), June 2036 (A3.350%), February 2037 (A3.350%), June 2044 (A3.550%), February 2045 (A3.600%), and February 2055 (A3.700%).
What is the filing date of this 10-Q report?
This 10-Q report was filed on April 23, 2025.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on April 23, 2025 regarding JOHNSON & JOHNSON (JNJ).